Myriad Case Decided: Natural Human Genes Not Patentable In US 14/06/2013 by Intellectual Property Watch 3 Comments The United States Supreme Court came to a decision yesterday on the case of Association for Molecular Pathology v. Myriad Genetics, Inc., striking down Myriad’s patent on isolating human genes from the bloodstream.
UN Human Rights Council Adopts Resolution Promoting Medicines Access 13/06/2013 by Intellectual Property Watch 1 Comment The United Nations Human Rights Council today adopted a resolution urging governments to encourage technology development and transfer and to apply intellectual property rights measures in ways that avoid creating barriers to trade in “affordable, safe, efficacious and quality medicines.” The resolution includes references to IP flexibilities in international trade law and to “delinkage” of R&D costs with the price of health products.
UK Intellectual Property Office Seeks Comment On Copyright Exceptions 13/06/2013 by Intellectual Property Watch Leave a Comment Draft legislation updating UK copyright exceptions is out for comment, the Intellectual Property Office (IPO) has said.
WHO Updates Guidance For Pandemic Flu Risk Management 13/06/2013 by Intellectual Property Watch 2 Comments The World Health Organization (WHO) has released an updated guidance document on pandemic influenza risk management, which includes the Pandemic Influenza Preparedness (PIP) Framework for the sharing of influenza viruses and access to vaccines and other benefits that was discussed by member states during the 66th World Health Assembly (WHA) in May.
Geneva Study Finds ‘Evergreening’ Increases Healthcare Costs 12/06/2013 by Intellectual Property Watch 2 Comments A recent Geneva-based study found that so-called evergreening practices utilised by drug manufacturers are successful in protecting profits by maintaining company market share and offsetting generic competition and cost containment policies.
ICANN Accepts Some Government Advice On New TLDs 09/06/2013 by Intellectual Property Watch 1 Comment The Internet Corporation for Assigned Names and Numbers (ICANN) this week accepted another set of advice from its Government Advisory Committee (GAC) with regard to new top-level domain applications.
EU Court Backs Secrecy, Privileged Industry Access In Trade Talks 07/06/2013 by Intellectual Property Watch Leave a Comment Secrecy in trade negotiations and privileged access for business and trade associations does not violate EU law, according to a judgment handed in by the Court of the European Union in Luxembourg today.
IP5 Discuss Patent Harmonisation 06/06/2013 by Intellectual Property Watch 1 Comment Officials from the IP5, the five largest intellectual property offices in the world, met this week to move forward on harmonising patent law procedure between the offices.
Author Cites Persistent Tobacco Industry Attempts To Influence WHO 05/06/2013 by Intellectual Property Watch Leave a Comment Thirteen years after publication of the landmark report, “Tobacco Company Strategies to Undermine Tobacco Control Activities at the World Health Organization,” little has changed and industry manipulations continue, one of the lead authors has said.
Data From Clinical Trials Identify Gaps In Health R&D 05/06/2013 by Intellectual Property Watch Leave a Comment Lower-income countries receive much less attention in terms of clinical trial research, according to a study published in this month’s World Health Organization (WHO) Bulletin. The study also underscored the value and importance the WHO International Clinical Trials Registry Platform (ICTRP) provides as a resource for evaluating the distribution of clinical trials around the world, and for providing information for future policy on health R&D.